{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiclj7erqwgpe5bavjorzp4jsrt5zweuii3p2ob42u6dk54n7yubia",
    "uri": "at://did:plc:wwyqal4cnqhuwyacdj7rqq3n/app.bsky.feed.post/3mg2hzps5aji2"
  },
  "path": "/t/fda-draft-guidance-use-of-bayesian-methodology-in-clinical-trials-of-drug-and-biological-products/28598#post_9",
  "publishedAt": "2026-03-01T14:28:07.000Z",
  "site": "https://discourse.datamethods.org",
  "tags": [
    "linkedin.com",
    "Beware of the Morlocks:"
  ],
  "textContent": "Stephen Senn has a post on LinkedIn discussing the FDA Bayesian guidance, and some complexities of adaptive trials that might not be obvious.\n\nlinkedin.com\n\n### Beware of the Morlocks:\n\nIf you use a Bayesian Time Machine you may be in for some surprises \"It sounds plausible enough tonight,” said the Medical Man; “but wait until tomorrow. Wait for the common sense of the morning.\n\nReading time: 8 min read",
  "title": "FDA Draft Guidance: Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products"
}